NATCO 30 (Lansoprazole delayed-release 30 mg)

Pill imprint NATCO 30 has been identified as Lansoprazole delayed-release 30 mg.

Lansoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; gerd; helicobacter pylori infection; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for NATCO 30 (Lansoprazole delayed-release 30 mg)

Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release
30 mg
Blue & Pink
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Breckenridge Pharmaceutical, Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)